MetaCap

CytomX Therapeutics Statistics

NASDAQ: CTMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.03-0.02 (-0.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CytomX Therapeutics by the numbers

CytomX Therapeutics has a market capitalization of $442.5 million based on 218.00M shares outstanding. With trailing EPS of $-0.51, CytomX Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.8% below its 50-day average and 43.8% below its 200-day average.

Average daily trading volume is 4.27M shares, or about $8.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CTMX valuation vs. peer median

CTMX compared with the median of 8 peer companies
MetricCTMXPeer medianDifference
Market cap$442.55M$446.00M-1%
Avg. volume4.27M259.12K+1547%

Peer median across 8 companies: KMDA, DMAC, AMRN, LYEL, CAPR, STTK, ASMB, NGNE.

Valuation

Market cap
$442.55M
Price / sales (latest FY)
5.81
EPS (TTM)
$-0.51

Price and trading

Previous close
2.05
Open
2.02
Day range
1.97 – 2.16
52-week range
1.87 – 8.21
52-week change
-47.68%
Beta
—
Volume
4.87M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
442.55M
Forward Pe
-4.07
Eps
-0.51
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
8.21
Week52 Low
1.87
Avg Volume
4.27M
Shares Outstanding
218.00M
Ma50
2.41
Ma200
3.61
Earnings Date
Nov 5, 2026
Pct From52w High
-75.27%
Pct From52w Low
8.56%

Related